Weekly News Recap #Phispers
AbbVie doubles down on immunology with US$ 2.1 bn Capstan buyout; India’s Torrent buys controlling stake in JB Chem
This week in Phispers, AbbVie struck a deal worth up to US$ 2.1 billion to acquire Capstan Therapeutics and its innovative in v...
Impressions : 835
Astra invests US$ 2 bn in US R&D; key AbbVie asset from US$ 8.7 bn Cerevel buy flunks phase 2 trials
This week’s Phispers is packed with news about deals. First, AstraZeneca announced a US$ 2 billion investment in the...
Impressions : 1087
Six CAR-T therapies to carry boxed warning for secondary cancer; Sanofi buys Inhibrx for about US$ 2.2 billion
The US Food and Drug Administration (FDA) has mandated “black box” warnings on six major CAR-T cancer therapies ove...
Impressions : 2732
Gilead loses patent case to Bristol-Myers over its CAR-T therapy; Amneal beats Dr. Reddy’s on key generic approval
This week, Phispers brings you news on Bristol-Myers Squibb winning a patent case against Gilead’s Yescarta — a US$...
Impressions : 1954
Big pharma slash prices for China’s insurance scheme; plan major investments in gene therapy
This week, Phispers brings you news on 11 large multinational drugmakers, including Pfizer and Novartis, that have set aside US...
Impressions : 2177
New Twists to Sartans Impurities Saga; Fish Oil Drug Makes Heart Medicine History
This week, Phispers brings you new twists to the valsartan impurities saga.
First, the FDA posted its observations at Zhejiang...
Impressions : 3647
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.